{"title":"实体器官移植患者侵袭性真菌感染的治疗","authors":"O. Kaya","doi":"10.5152/kd.2019.63","DOIUrl":null,"url":null,"abstract":"The number of patients undergoing solid organ transplantation is increasing. Invasive fungal infection (IFI) is an important cause of graft loss and mortality in these patients. Invasive candidiasis is the most common IFI in solid organ transplant recipients. Because of lack of randomized controlled trials, antifungal treatments should be performed as recommended for other immunosuppressed hosts. Drug interactions should be considered when using azol groups. Klimik Dergisi 2019; 32(Suppl. 2): 174-6.","PeriodicalId":17826,"journal":{"name":"Klimik Dergisi/Klimik Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of Invasive Fungal Infections in Patients With Solid Organ Transplants\",\"authors\":\"O. Kaya\",\"doi\":\"10.5152/kd.2019.63\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The number of patients undergoing solid organ transplantation is increasing. Invasive fungal infection (IFI) is an important cause of graft loss and mortality in these patients. Invasive candidiasis is the most common IFI in solid organ transplant recipients. Because of lack of randomized controlled trials, antifungal treatments should be performed as recommended for other immunosuppressed hosts. Drug interactions should be considered when using azol groups. Klimik Dergisi 2019; 32(Suppl. 2): 174-6.\",\"PeriodicalId\":17826,\"journal\":{\"name\":\"Klimik Dergisi/Klimik Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klimik Dergisi/Klimik Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5152/kd.2019.63\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klimik Dergisi/Klimik Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/kd.2019.63","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
接受实体器官移植的病人越来越多。侵袭性真菌感染(IFI)是这些患者移植物丢失和死亡的重要原因。侵袭性念珠菌病是实体器官移植受者中最常见的IFI。由于缺乏随机对照试验，抗真菌治疗应像推荐的那样用于其他免疫抑制宿主。使用偶氮基团时应考虑药物相互作用。Klimik Dergisi 2019;32(5。2): 174 - 6。
Treatment of Invasive Fungal Infections in Patients With Solid Organ Transplants
The number of patients undergoing solid organ transplantation is increasing. Invasive fungal infection (IFI) is an important cause of graft loss and mortality in these patients. Invasive candidiasis is the most common IFI in solid organ transplant recipients. Because of lack of randomized controlled trials, antifungal treatments should be performed as recommended for other immunosuppressed hosts. Drug interactions should be considered when using azol groups. Klimik Dergisi 2019; 32(Suppl. 2): 174-6.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
